Notices for publication in the OJ nº T-664/19 of Tribunal General de la Unión Europea, December 11, 2020

• Resolution Date: December 11, 2020
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-664/19

Judgment of the General Court of 18 November 2020 - Allergan Holdings France v EUIPO - Dermavita (JUVEDERM ULTRA)

(Case T-664/19) ¹

(EU trade mark - Revocation proceedings - EU word mark JUVEDERM ULTRA - Genuine use of the mark - Use in connection with the goods in respect of which the mark was registered - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))

Language of the case: English

Parties

Applicant: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Crespo Carrillo, V.J. Ruzek, and K. Zajfert, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: D. Todorov, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 18 July 2019 (Joined Cases R 1655/2018-4 and R 1723/2018-4), relating to revocation proceedings between Dermavita Co. and Allergan Holdings France.

Operative part of the...